Cites del registre
Cita APA (7th ed.)
Colaneri, M., Scaglione, G., Fassio, F., Galli, L., Lai, A., Bergna, A., . . . Schiavini, M. (2024). Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease. BMC.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Colaneri, Marta, et al. Early Administration of Nirmatrelvir/ritonavir Leads to Faster Negative SARS-CoV-2 Nasal Swabs than Monoclonal Antibodies in COVID 19 Patients at High-risk for Severe Disease. BMC, 2024.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Colaneri, Marta, et al. Early Administration of Nirmatrelvir/ritonavir Leads to Faster Negative SARS-CoV-2 Nasal Swabs than Monoclonal Antibodies in COVID 19 Patients at High-risk for Severe Disease. BMC, 2024.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.